Home > Insider Trading > Filing (0001104659-20-116865)

Filing Details

Accession Number:: 0001104659-20-116865
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-10-21 19:58:54
Reporting Period:: 2020-08-07

Accepted Time:: 2020-10-21 19:58:54
Original Submission Date:: 2020-08-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371285	Trupanion Inc.	TRUP	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202435	Dan Levitan	411 First Avenue South, Suite 600 Seattle WA 98104		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-08-07	426,934	$0.00	0	No	4	J	Indirect	See footnote
Common Stock	Acquisiton	2020-08-07	88,802	$0.00	114,509	No	4	J	Indirect	See footnote
Common Stock	Disposition	2020-08-07	58,538	$0.00	0	No	4	J	Indirect	See footnote
Common Stock	Disposition	2020-08-07	13,114	$0.00	5,000	No	4	J	Indirect	See footnote
Common Stock	Acquisiton	2020-08-07	2,728	$0.00	117,237	No	4	J	Indirect	See footnote
Common Stock	Disposition	2020-08-07	114,393	$0.00	2,844	No	4	J	Indirect	See footnote
Common Stock	Acquisiton	2020-08-07	21,918	$0.00	26,734	No	4	J	Indirect	See footnote
Common Stock	Acquisiton	2020-08-07	219	$0.00	26,953	No	4	J	Indirect	See footnote
Common Stock	Disposition	2020-08-07	21,566	$0.00	5,387	No	4	J	Indirect	See footnote
Common Stock	Acquisiton	2020-08-07	12,797	$0.00	99,178	No	4	J	Direct
Common Stock	Acquisiton	2020-08-07	9,258	$0.00	108,436	No	4	J	Direct
Common Stock	Acquisiton	2020-08-07	34,995	$0.00	143,431	No	4	J	Direct
Common Stock	Disposition	2020-08-07	25,000	$70.01	118,431	No	4	S	Direct
Common Stock	Disposition	2020-08-07	7,173	$69.63	111,258	No	4	S	Direct
Common Stock	Disposition	2020-08-07	2,827	$70.10	2,173	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	2,046	$70.69	127	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	127	$71.53	0	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	1,608	$70.10	1,236	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	1,163	$70.69	73	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	73	$71.53	0	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	552	$69.85	4,835	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-07	20,950	$70.04	0	No	4	S	Indirect	By Trust - Levitan Family Foundation
Common Stock	Acquisiton	2020-08-07	20,482	$8.57	131,740	No	4	M	Direct
Common Stock	Disposition	2020-08-07	20,482	$69.71	111,258	No	4	S	Direct
Common Stock	Acquisiton	2020-08-07	12,688	$16.06	123,946	No	4	M	Direct
Common Stock	Disposition	2020-08-07	12,688	$69.71	111,258	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	By Trust - Levitan Family Foundation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-08-07	20,482	$0.00	20,482	$8.57
Common Stock	Stock Option (right to buy)	Disposition	2020-08-07	12,688	$0.00	12,688	$16.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-05	No	4	M	Direct
0		2024-09-26	No	4	M	Direct

Footnotes

Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 426,934 shares of common stock of the issuer to its partners on August 7, 2020.
Shares owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 58,538 shares of common stock of the issuer to its partners on August 7, 2020.
Shares owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 13,114 shares of common stock of the issuer to its partners on August 7, 2020.
Shares owned directly by Maveron Entrepreneurs. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Entrepreneurs, and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Maveron GP distributed for no consideration 114,393 shares of common stock of the issuer to its members on August 7, 2020.
Shares owned directly by Maveron GP.
Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron GP.
Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates.
Maveron LLC distributed for no consideration 21,566 shares of common stock of the issuer to its members on August 7, 2020.
Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron LLC.
Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron Associates.
Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron GP.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.34 to $69.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.48 to $70.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares owned directly by Maveron Entrepreneurs.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.48 to $71.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.49 to $71.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.48 to $70.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares owned directly by Maveron GP.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.48 to $71.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.49 to $71.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.82 to $69.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares owned directly by Maveron LLC.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.93 to $70.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares are held by a trust the holdings of which are attributable to the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.34 to $70.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This stock option grant is fully vested.